RG9MTD2 Antikörper
Kurzübersicht für RG9MTD2 Antikörper (ABIN7469636)
Target
Alle RG9MTD2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Purified by antigen-affinity chromatography.
-
Immunogen
- Recombinant protein encompassing a sequence within the center region of human RG9MTD2. The exact sequence is proprietary.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB: 1:500-1:3000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Kommentare
-
Positive Control: NT2D1
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.61 mg/mL
-
Buffer
- 0.1M Tris-Glycine ( pH 7), 20 % Glycerol, 0.01 % Thimerosal
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- RG9MTD2 (RNA (Guanine-9-) Methyltransferase Domain Containing 2 (RG9MTD2))
-
Andere Bezeichnung
- RG9MTD2
-
Hintergrund
-
Synonyms: tRNA methyltransferase 10A , HEL-S-88 , MSSGM , MSSGM1 , RG9MTD2 , TRM10
Background: Probable RNA methyltransferase.
-
Molekulargewicht
- 40 kDa
-
Gen-ID
- 93587
-
UniProt
- Q8TBZ6
Target
-